RIPK2 and neoplasm: We were able to obtain eight tumor matched tissues of the same IBC patients at diagnosis and post-neoadjuvant chemotherapy and immmunohistochemically stained them with a RIPK2 phospho-Y474 antibody as a surrogate marker for active RIPK2.